5398
慕康生醫
0.00 (0.00%)14.2515成交張數142.50本益比1.36股價淨值比0.00%殖利率2026-09-15資料日期
綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入
營業收入2025230年增 -3.6%
毛利率202537.1%最新一期
營業利益率20255.2%最新一期
每股盈餘20250.35年增 +66.7%
| 會計項目 | 走勢 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業收入合計 | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 營業成本合計 | 67.7% | 67.7% | 74.2% | 68.3% | 65.7% | 66.6% | 74.5% | 82.7% | 64.6% | 62.9% | |
| 營業毛利（毛損） | 32.3% | 32.3% | 25.8% | 31.7% | 34.3% | 33.4% | 25.5% | 17.3% | 35.4% | 37.1% | |
| 營業毛利（毛損）淨額 | 32.3% | 32.3% | 25.8% | 31.7% | 34.3% | 33.4% | 25.5% | 17.3% | 35.4% | 37.1% | |
| 推銷費用 | 4.1% | 12.4% | 15.3% | 18.7% | 17.8% | 15.0% | 17.1% | 21.9% | 18.0% | 12.7% | |
| 管理費用 | 21.2% | 18.9% | 14.2% | 10.9% | 10.5% | 9.2% | 12.3% | 14.5% | 13.8% | 17.8% | |
| 研究發展費用 | 1.9% | 2.0% | 2.6% | 2.4% | 2.6% | 2.3% | 1.8% | 2.2% | 0.9% | 1.4% | |
| 預期信用減損損失（利益） | – | – | 1.1% | -0.5% | 0.1% | 0.1% | -0.8% | 0.0% | 0.2% | 0.0% | |
| 營業費用合計 | 27.2% | 33.3% | 33.2% | 31.5% | 31.0% | 26.7% | 30.4% | 38.6% | 32.9% | 31.9% | |
| 營業利益（損失） | 5.1% | -1.0% | -7.4% | 0.3% | 3.3% | 6.8% | -4.9% | -21.3% | 2.6% | 5.2% | |
| 利息收入 | – | – | – | – | 0.3% | 0.2% | 0.3% | 0.8% | 0.6% | 0.9% | |
| 其他收入 | 2.3% | 1.8% | 1.0% | 4.3% | 1.5% | 1.6% | 3.9% | 5.7% | 8.1% | 7.8% | |
| 其他利益及損失淨額 | -3.8% | 3.3% | -5.0% | 1.5% | -0.3% | -2.7% | -1.1% | -0.9% | -4.3% | -3.3% | |
| 財務成本淨額 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.1% | 0.2% | 0.4% | 0.2% | |
| 營業外收入及支出合計 | -1.5% | 5.1% | -4.0% | 5.7% | 1.4% | -0.9% | 3.0% | 5.4% | 4.1% | 5.2% | |
| 稅前淨利（淨損） | 3.6% | 4.1% | -11.4% | 6.0% | 4.8% | 5.9% | -1.9% | -15.9% | 6.6% | 10.4% | |
| 所得稅費用（利益）合計 | 0.9% | 0.8% | 0.3% | 0.1% | 0.3% | 1.3% | 0.8% | 0.6% | 2.3% | 2.8% | |
| 繼續營業單位本期淨利（淨損） | 2.7% | 3.3% | -11.7% | 5.8% | 4.5% | 4.6% | -2.6% | -16.5% | 4.4% | 7.6% | |
| 本期淨利（淨損） | 2.7% | 3.3% | -11.7% | 5.8% | 4.5% | 4.6% | -2.6% | -16.5% | 4.4% | 7.6% | |
| 透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益 | – | – | -0.5% | 0.1% | 0.9% | -2.1% | -4.6% | -1.6% | 13.2% | -13.9% | |
| 不重分類至損益之項目： | – | – | – | 0.1% | 0.9% | -2.1% | -4.6% | -1.6% | 13.2% | -13.9% | |
| 國外營運機構財務報表換算之兌換差額 | -1.3% | -0.1% | -2.7% | -0.2% | -0.3% | -0.1% | 0.8% | -0.0% | 0.6% | -0.4% | |
| 後續可能重分類至損益之項目： | – | – | – | -0.2% | -0.3% | -0.1% | 0.8% | -0.0% | 0.6% | -0.4% | |
| 其他綜合損益（淨額） | -1.1% | 0.6% | -3.2% | -0.1% | 0.6% | -2.2% | -3.9% | -1.6% | 13.8% | -14.3% | |
| 本期綜合損益總額 | 1.6% | 3.9% | -14.9% | 5.7% | 5.2% | 2.4% | -6.5% | -18.1% | 18.1% | -6.8% | |
| 母公司業主（淨利∕損） | 2.7% | 3.3% | -11.7% | 5.8% | 4.5% | 4.6% | -2.6% | -16.5% | 4.4% | 7.6% | |
| 母公司業主（綜合損益） | 1.6% | 3.9% | -14.9% | 5.7% | 5.2% | 2.4% | -6.5% | -18.1% | 18.1% | -6.8% | |
| 基本每股盈餘 | 0.1% | 0.1% | -0.2% | 0.1% | 0.1% | 0.1% | -0.1% | -0.3% | 0.1% | 0.2% | |
| 稀釋每股盈餘 | 0.0% | 0.1% | 0.0% | 0.1% | 0.1% | 0.1% | -0.1% | -0.3% | 0.1% | 0.2% | |
| 銷貨收入 | 99.5% | 99.2% | 99.1% | 98.6% | 99.1% | – | – | – | – | – | |
| 銷貨收入淨額 | 99.5% | 99.2% | 99.1% | 98.6% | 99.1% | – | – | – | – | – | |
| 勞務收入淨額 | 0.5% | 0.8% | 0.9% | 1.4% | 0.9% | – | – | – | – | – | |
| 勞務收入 | 0.5% | 0.8% | 0.9% | 1.4% | 0.9% | – | – | – | – | – | |
| 銷貨成本 | 67.7% | 67.7% | 74.2% | 68.3% | 65.7% | – | – | – | – | – | |
| 繼續營業單位淨利（淨損） | 0.0% | 0.0% | -0.0% | 0.0% | 0.0% | – | – | – | – | – | |
| 備供出售金融資產未實現評價損益 | 0.2% | 0.7% | 0.0% | – | – | – | – | – | – | – |
金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。